Daniel Ojeda Juarez, Ph.D.

246 posts

Daniel Ojeda Juarez, Ph.D.

Daniel Ojeda Juarez, Ph.D.

@DanOjedaJuarez

UC President’s Postdoctoral Fellow at UCSD Neurodegeneration, prion disease, neuroinflammation, and NeuroAIDS

Katılım Nisan 2015
428 Takip Edilen142 Takipçiler
Ran Blekhman
Ran Blekhman@blekhman·
Claude Science is incredible. I gave it some sequencing data, and in 8 hours it did a full analysis, generated figures, wrote a paper, submitted it for publication, got rejected, revised and resubmitted, got rejected again, it is now applying for positions in industry
English
103
674
9.1K
494.2K
Daniel Ojeda Juarez, Ph.D.
Daniel Ojeda Juarez, Ph.D.@DanOjedaJuarez·
@MuruLago Tristemente, este tipo de contrato es cada vez más común debido a la situación actual de los fondos para investigación en Estados Unidos y la Unión Europea.
Español
0
0
2
154
Daniel Ojeda Juarez, Ph.D. retweetledi
Adriano Aguzzi
Adriano Aguzzi@AdrianoAguzzi·
ISAB is hiring a grant manager! Tasks include accounting, grant writing/reporting, coordination with scientists and officials, etc. One day/week presence required in St. Gallen, the rest remotely. Working hours are flexible. isab.science/jobs/grant-man…
Adriano Aguzzi tweet media
English
2
9
17
3.6K
Daniel Ojeda Juarez, Ph.D.
Daniel Ojeda Juarez, Ph.D.@DanOjedaJuarez·
I wonder how many millions of dollars and hours were wasted trying to troubleshoot these antibodies 🫩. How should @thermofisher respond and should they compensate scientists that brought their antibodies?
nature@Nature

Catalogue entries for more than 100 antibodies sold by the research services and supply company Thermo Fisher Scientific contain images that have apparently been manipulated, according to a pair of science sleuths. go.nature.com/4wZqGEE

English
0
0
0
214
Daniel Ojeda Juarez, Ph.D.
Daniel Ojeda Juarez, Ph.D.@DanOjedaJuarez·
Acknowledging CJD as an ADRD opens the door to a more collaborative research landscape. If the mechanisms of seeding and spreading are shared, our strategies for intervention could be as well.
English
1
0
0
20
Daniel Ojeda Juarez, Ph.D.
Daniel Ojeda Juarez, Ph.D.@DanOjedaJuarez·
The prion disease field pioneered our understanding of how protein aggregates drive neurodegeneration, and continues to yield breakthroughs for AD and Related Dementias. A new paper argues it’s time to bridge the gap between human prion diseases (#CJD, #FFI, and #GSS) and ADRD
English
1
0
0
45
Daniel Ojeda Juarez, Ph.D.
Daniel Ojeda Juarez, Ph.D.@DanOjedaJuarez·
Science is a team sport! 🧪 It wouldn't be possible without the contributions of our incredible student researchers. For #NSEW2026, a massive shout-out to Sammy Sokolowski & Thalia Crawford for advancing our understanding of Prion diseases & Alzheimer’s pathways #CJD #Alzheimers
Daniel Ojeda Juarez, Ph.D. tweet media
English
0
0
1
66
Daniel Ojeda Juarez, Ph.D. retweetledi
UC San Diego Neurosciences
UC San Diego Neurosciences@ucsdneurodept·
Please join us on Tuesday, 4/21 at 9am for the Shiley-Marcos Alzheimer’s Disease Research Center Neurodegeneration Seminar Series. We are pleased to announce that Dr. David Coughlin and Dr. Vanessa Goodwill will be presenting, 'Clinico-pathologic Conference'. More info in flyer.
UC San Diego Neurosciences tweet media
English
0
1
1
96
Daniel Ojeda Juarez, Ph.D. retweetledi
UC San Diego Neurosciences
UC San Diego Neurosciences@ucsdneurodept·
We are excited to announce that the 2026 Schedule for the Shiley-Marcos Neurodegeneration Seminar is now finalized with an excellent lineup of esteemed academic presenters.
UC San Diego Neurosciences tweet media
English
0
1
2
77